New Key Statistics Module, Z-Score and F-Score
SZSE:300109 Key Ratios
Market Cap ¥ M | 6,738.54 |
Enterprise Value ¥ M | 6,515.16 |
P/E(ttm) | 13.71 |
PE Ratio without NRI | 13.34 |
Forward PE Ratio | -- |
Price/Book | 1.85 |
Price/Sales | 4.20 |
Price/Free Cash Flow | 40.90 |
Price/Owner Earnings | 22.41 |
Payout Ratio % | 0.32 |
Revenue (TTM) ¥ M | 1,615.00 |
EPS (TTM) ¥ | 1.53 |
Beneish M-Score | -2.56 |
10-y EBITDA Growth Rate % | 18.60 |
5-y EBITDA Growth Rate % | 20.30 |
y-y EBITDA Growth Rate % | 16.70 |
EV-to-EBIT | 11.34 |
EV-to-EBITDA | 11.34 |
PEG | 0.66 |
Shares Outstanding M | 323.50 |
Net Margin (%) | 30.61 |
Operating Margin % | 36.04 |
Pre-tax Margin (%) | 35.47 |
Quick Ratio | 2.23 |
Current Ratio | 2.94 |
ROA % (ttm) | 12.59 |
ROE % (ttm) | 14.37 |
ROIC % (ttm) | 15.48 |
Dividend Yield % | 2.40 |
Altman Z-Score | 10.29 |
SZSE:300109 Number of Guru Trades
SZSE:300109 Volume of Guru Trades
Gurus Latest Trades with SZSE:300109
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300109 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NKY Medical Holdings Ltd Insider Transactions
No Available Data